Bio-Rad Laboratories Inc (BIO-B)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $10.49B
Last updated: Nov 17, 2026 at 4:00 PM ET
Bio-Rad Laboratories Inc (BIO-B) Stock Chart
Bio-Rad Laboratories (BIO-B) closed at $367.05 on Nov 17, 2026, 5.9% below its 52-week high of $389.98. Its price rose 16.7% over the past 12 months. The month-end price rose 132.8% over the 10 years through Oct 2026, a compound annual rate of 8.8%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $762.80 in Aug 2021 and its lowest $163.00 in Oct 2016, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart BIO-B with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for BIO-B.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 8.9%, and over 6 months it rose 37.3%. The month-end price rose 39.0% over the 3 years through Oct 2026, a compound annual rate of 11.6%.
| Period | Change |
|---|---|
| 1 month | +0.8% |
| 3 months | +8.9% |
| 6 months | +37.3% |
| 12 months | +16.7% |
| 12 months, with dividends | +16.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +39.0% | +11.6% |
| 5 years | -48.0% | -12.3% |
| 10 years | +132.8% | +8.8% |
Price by Year
Its best calendar year was 2019, when the price rose 60.7%, and its weakest was 2022, when it fell 44.0%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $379.50 | +22.1% |
| 2025 | $310.70 | -4.6% |
| 2024 | $325.60 | +1.5% |
| 2023 | $320.65 | -20.8% |
| 2022 | $404.66 | -44.0% |
| 2021 | $722.91 | +25.9% |
| 2020 | $574.15 | +55.3% |
| 2019 | $369.60 | +60.7% |
| 2018 | $230.00 | -3.5% |
| 2017 | $238.25 | +30.1% |
Trading Range
The price is 0.9% below its 50-day average of $370.54 and 16.4% above its 200-day average of $315.41.
| Measure | Value | Price vs |
|---|---|---|
| Close (Nov 17, 2026) | $367.05 | |
| 52-week high | $389.98 | -5.9% |
| 52-week low | $244.54 | +50.1% |
| 50-day average | $370.54 | -0.9% |
| 200-day average | $315.41 | +16.4% |
Price Risk
Over 3 years, its largest fall from a peak was 37.0%.
| Measure | Value |
|---|---|
| 1-year beta | 0.13 |
| Largest fall, 1 year | -18.3% |
| Largest fall, 3 years | -37.0% |
Valuation
Bio-Rad Laboratories traded at 11.1x earnings at the end of 2025, against a 10-year median of 46.7x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About BIO-B
What is BIO-B's 1-year price change?
Bio-Rad Laboratories's price rose 16.7% over the past 12 months. With dividends included, the 12-month total return was 16.7%.
What is BIO-B's 5-year price change?
Bio-Rad Laboratories's month-end price fell 48.0% over the 5 years through Oct 2026, a compound annual decline of 12.3%. These figures leave out dividends.
What is BIO-B's 52-week high and low?
Bio-Rad Laboratories's 52-week high is $389.98 and its 52-week low is $244.54. Its close of $367.05 on Nov 17, 2026 is 5.9% below the high.
What is BIO-B's beta?
Bio-Rad Laboratories's 1-year beta against the S&P 500 is 0.13, so its price has shown little link to the market's moves over the past year. Its largest fall from a peak over the past year was 18.3%.
Is the BIO-B chart free?
Yes. Advanced Charting for BIO-B is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
BIO-B pages: Overview, Charting, Earnings, Financials, Statistics, Valuation, Competitors